Novo Nordisk to Cut Ozempic & Wegovy List Prices Up to 50% in 2027
Novo Nordisk plans major U.S. list price cuts for Ozempic and Wegovy starting January 2027 Intro Novo Nordisk says it will lower the U.S. list prices of its blockbuster GLP-1 medicines — Wegovy, Ozempic, and Rybelsus — starting January 1, 2027. The company says the goal is to reduce out-of-pocket costs for people whose payments
Novo Nordisk to Cut Ozempic & Wegovy List Prices Up to 50% in 2027 Read More »